APA

Papadimitriou C. A., Moulopoulos L. A., Vlahos G., Voulgaris Z., Kiosses E., Georgoulias N., Gika D., Diakomanolis E., Michalas S. & Dimopoulos M. A. (20001017). Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study. : Cancer.

Chicago

Papadimitriou C A, Moulopoulos L A, Vlahos G, Voulgaris Z, Kiosses E, Georgoulias N, Gika D, Diakomanolis E, Michalas S and Dimopoulos M A. 20001017. Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study. : Cancer.

Harvard

Papadimitriou C. A., Moulopoulos L. A., Vlahos G., Voulgaris Z., Kiosses E., Georgoulias N., Gika D., Diakomanolis E., Michalas S. and Dimopoulos M. A. (20001017). Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study. : Cancer.

MLA

Papadimitriou C A, Moulopoulos L A, Vlahos G, Voulgaris Z, Kiosses E, Georgoulias N, Gika D, Diakomanolis E, Michalas S and Dimopoulos M A. Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study. : Cancer. 20001017.